Laura Hamill insider trades

Open-market stock purchases and sales by Laura Hamill, Director at Jazz Pharmaceuticals plc, from SEC Form 4 filings since Oct 7, 2018.

Recent trades

DateStockTradeValue
Aug 31, 2026JAZZ Jazz Pharmaceuticals plcSold (not open market)$3.4K
Aug 31, 2026JAZZ Jazz Pharmaceuticals plcSold (not open market)$408K
Aug 5, 2026JAZZ Jazz Pharmaceuticals plcBought (not open market)—
Jun 12, 2026FATE Fate Therapeutics IncBought (not open market)—

Companies traded

  • JAZZ Jazz Pharmaceuticals plc: other filings, last Aug 31, 2026
  • FATE Fate Therapeutics Inc: other filings, last Jun 12, 2026
  • YMAB Y-mAbs Therapeutics, Inc: other filings, last Sep 16, 2025
  • PRDS Pardes Biosciences, Inc: other filings, last Aug 31, 2023
  • SCLX Scilex Holding Co: other filings, last Jan 17, 2023
  • ANAB Anaptysbio, Inc: other filings, last Jan 6, 2023
  • XLRN Acceleron Pharma Inc: other filings, last Nov 19, 2021
  • GILD Gilead Sciences Inc: other filings, last May 8, 2019

Get free alerts when Laura Hamill files a new trade →